1. Home
  2. CNXC vs ICUI Comparison

CNXC vs ICUI Comparison

Compare CNXC & ICUI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CNXC
  • ICUI
  • Stock Information
  • Founded
  • CNXC 1991
  • ICUI 1984
  • Country
  • CNXC United States
  • ICUI United States
  • Employees
  • CNXC N/A
  • ICUI N/A
  • Industry
  • CNXC Computer Software: Prepackaged Software
  • ICUI Medical/Dental Instruments
  • Sector
  • CNXC Technology
  • ICUI Health Care
  • Exchange
  • CNXC Nasdaq
  • ICUI Nasdaq
  • Market Cap
  • CNXC 3.6B
  • ICUI 3.2B
  • IPO Year
  • CNXC N/A
  • ICUI 1992
  • Fundamental
  • Price
  • CNXC $35.97
  • ICUI $152.46
  • Analyst Decision
  • CNXC Strong Buy
  • ICUI Buy
  • Analyst Count
  • CNXC 5
  • ICUI 6
  • Target Price
  • CNXC $69.00
  • ICUI $183.60
  • AVG Volume (30 Days)
  • CNXC 1.2M
  • ICUI 314.7K
  • Earning Date
  • CNXC 01-14-2026
  • ICUI 11-06-2025
  • Dividend Yield
  • CNXC 4.00%
  • ICUI N/A
  • EPS Growth
  • CNXC 54.10
  • ICUI N/A
  • EPS
  • CNXC 4.74
  • ICUI N/A
  • Revenue
  • CNXC $9,720,870,000.00
  • ICUI $2,320,363,000.00
  • Revenue This Year
  • CNXC $4.00
  • ICUI N/A
  • Revenue Next Year
  • CNXC $3.24
  • ICUI N/A
  • P/E Ratio
  • CNXC $7.58
  • ICUI N/A
  • Revenue Growth
  • CNXC 3.40
  • ICUI N/A
  • 52 Week Low
  • CNXC $31.63
  • ICUI $107.00
  • 52 Week High
  • CNXC $66.00
  • ICUI $175.51
  • Technical
  • Relative Strength Index (RSI)
  • CNXC 39.93
  • ICUI 74.65
  • Support Level
  • CNXC $31.63
  • ICUI $131.99
  • Resistance Level
  • CNXC $36.52
  • ICUI $138.48
  • Average True Range (ATR)
  • CNXC 1.64
  • ICUI 6.36
  • MACD
  • CNXC 0.45
  • ICUI 1.42
  • Stochastic Oscillator
  • CNXC 58.93
  • ICUI 96.21

About CNXC Concentrix Corporation

Concentrix Corp is a technology enabled company specialized in customer engagement and customer management. The company provides end-to-end capabilities, including CX process optimization, technology innovation and design engineering, front- and back-office automation, analytics and business transformation services to clients in five industry verticals. The Company's verticals are technology and consumer electronics, retail, travel and e-commerce, communications and media, banking, financial services and insurance, and healthcare. Geographically, the company operates in Philippines, Unites States, India, Frances and Others. Maximum revenue is from Technology and consumer electronics industry and geographically from Philippines.

About ICUI ICU Medical Inc.

ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (43% of consolidated revenue), infusion systems (28%), and vital care (29%). The combined entity remains primarily US-focused, generating over 63% of its sales domestically.

Share on Social Networks: